Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Equities
IL0006290147
Pharmaceuticals
Sales 2024 * | 15.96B 58.75B | Sales 2025 * | 16.55B 60.88B | Capitalization | 18.84B 69.31B |
---|---|---|---|---|---|
Net income 2024 * | 816M 3B | Net income 2025 * | 1.46B 5.38B | EV / Sales 2024 * | 2.12 x |
Net Debt 2024 * | 14.99B 55.15B | Net Debt 2025 * | 12.47B 45.89B | EV / Sales 2025 * | 1.89 x |
P/E ratio 2024 * |
17.5
x | P/E ratio 2025 * |
12.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.44% |
Latest transcript on Teva Pharmaceutical Industries Limited
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 22-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 19-12-21 |
Kathleen Veit
CMP | Compliance Officer | - | 09-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 15-08-31 |
Janet Vergis
BRD | Director/Board Member | 59 | 20-06-08 |
Sol Barer
CHM | Chairman | 76 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B |